3-methyl-5-(1-ethylpropyl)isoxazole | 83666-03-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3-methyl-5-(1-ethylpropyl)isoxazole
• 英文别名: 5-(1-Ethylpropyl)-3-methylisoxazole；3-Methyl-5-(pentan-3-yl)isoxazole；3-methyl-5-pentan-3-yl-1,2-oxazole
• CAS: 83666-03-9
• 化学式: C₉H₁₅NO
• 分子量: 153.224
• InChiKey: NBHMCZUZGAKZTP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  26
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2-ethyl-N-methoxy-N-methylbutanamide 、 丙酮肟 在 正丁基锂 、 硫酸 作用下， 生成 3-methyl-5-(1-ethylpropyl)isoxazole
  参考文献：
  名称：

  Regiospecific Synthesis of 3-Substituted 5-Alkylisoxazoles from Oxime Dianions and N-Methoxy-N-Methylalkylamides

  摘要：

  DOI：

  10.1021/jo00098a054

文献信息

• SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES
  申请人：Bayer Aktiengesellschaft

  公开号：US20200390100A1

  公开（公告）日：2020-12-17

  The present invention relates to substituted N-heterocyclyl- and N-heteroaryltetrahydropyrimidinones of the general formula (I) or salts thereof, where the radicals in the general formula (I) correspond to the definitions given in the description, and to the use thereof as herbicides, in particular for controlling broad-leaved weeds and/or weed grasses in crops of useful plants and/or as plant growth regulators for influencing the growth of crops of useful plants.

  本发明涉及通式（I）或其盐的取代N-杂环烷基和N-杂芳基四氢嘧啶酮，其中通式（I）中的基团对应于描述中给出的定义，并将其用作除草剂，特别是用于控制作物中的阔叶杂草和/或杂草草，并/或作为植物生长调节剂，以影响作物的生长。
• Regiospecific synthesis of 3-substituted-5-alkylisoxazoles by modification of the dilithiooxime route to isoxazoles
  作者：Dennis H. Hoskin、R. A. Olofson

  DOI：10.1021/jo00147a042

  日期：1982.12
• Nitz Theodore J., Volkots Deborah L., Aldous David J., Oglesby Richard C., J. Org. Chem, 59 (1994) N 19, S 5828-5832
  作者：Nitz Theodore J., Volkots Deborah L., Aldous David J., Oglesby Richard C.

  DOI：——

  日期：——
• HOSKIN, D. H.;OLOFSON, R. A., J. ORG. CHEM., 1982, 47, N 26, 5222-5225
  作者：HOSKIN, D. H.、OLOFSON, R. A.

  DOI：——

  日期：——
• Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
  申请人：AMGEN INC.

  公开号：US20170144971A1

  公开（公告）日：2017-05-25

  The present invention provides MDM2 inhibitor compounds of Formula I, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.